Stockreport

ACAD Signs License Deal With Saniona for Rights to Neurology Drug [Yahoo! Finance]

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF biopharmaceutical company, to develop and commercialize SAN711, a first-in-class, highly selective GABA A -a3 positive allosteric modulator. As its first indication, A [Read more]